# OrphanCure Full Pipeline Report: repodb_074e03e7fac6728e

- Drug: Irinotecan
- Disease: signet ring adenocarcinoma of the rectum
- Mode: full
- Status: completed
- Final assessment: Unlikely

This generated report is for research support only and is not medical advice.

## Structured Output

```json
{
  "sections": {
    "1_executive_summary": {
      "conclusion": "Unlikely",
      "confidence": "Low",
      "summary": "The provided literature does not contain information regarding the use of Irinotecan for rectal signet ring cell adenocarcinoma. The abstract focuses on the challenges of managing metastatic rectal SRCC and diagnostic aids, without mentioning specific treatments or Irinotecan.",
      "evidence_counts": {
        "total_papers": 1,
        "supporting": 0,
        "contradicting": 0,
        "inconclusive": 1
      },
      "common_targets_count": 0
    },
    "2_normalized_hypothesis": {
      "statement": "Repurpose IRINOTECAN for rectal signet ring cell adenocarcinoma",
      "drug": {
        "id": "CHEMBL481",
        "name": "IRINOTECAN",
        "aliases": [
          "CPT-11",
          "Camptosar",
          "Irinotecan hydrochloride",
          "Onivyde",
          "Topoisomerase 1 inhibitor"
        ],
        "resolution_method": "auto"
      },
      "disease": {
        "id": "MONDO_0004336",
        "name": "rectal signet ring cell adenocarcinoma",
        "aliases": [
          "Rectal signet-ring cell carcinoma",
          "Adenocarcinoma, signet ring cell, of rectum",
          "Signet ring cell adenocarcinoma of the rectum",
          "Rectal signet ring carcinoma",
          "Signet ring cell carcinoma, rectum"
        ],
        "resolution_method": "auto"
      }
    },
    "3_mechanistic_rationale": {
      "total_mechanisms": 0,
      "mechanisms": []
    },
    "4_target_overlap_summary": {
      "total_overlapping": 0,
      "top_targets": []
    },
    "5_literature_evidence_summary": {
      "total_retrieved": 1,
      "polarity": {
        "supports": 0,
        "contradicts": 0,
        "inconclusive": 1
      },
      "support_ratio": "0 of 1 retrieved papers support the hypothesis",
      "queries_used": 10,
      "top_papers": [
        {
          "pmid": "37483522",
          "title": "Case Report: Systemic treatment for breast and vulvar metastases from resected rectal signet ring cell carcinoma.",
          "year": "2023",
          "relevance_score": 5.0,
          "polarity": "INCONCLUSIVE",
          "match_reasons": [
            "Case report limit",
            "Recent"
          ]
        }
      ]
    },
    "6_contradictory_evidence": {
      "count": 0,
      "claims": []
    },
    "7_confidence_assessment": {
      "overall": "Low",
      "dimensions": {
        "mechanistic_strength": "Low",
        "literature_strength": "Low",
        "clinical_evidence": "Low"
      },
      "quality_scorecard": {
        "overall_score": 0.388,
        "decision": "rerun",
        "dimensions": {
          "completeness": {
            "score": 0.8,
            "reason": "4/5 sections present"
          },
          "evidence_support": {
            "score": 0.0,
            "reason": "No claims generated"
          },
          "citation_validity": {
            "score": 0.0,
            "reason": "0 total citations"
          },
          "mechanistic_specificity": {
            "score": 0.0,
            "reason": "0/0 claims reference targets"
          },
          "contradiction_handling": {
            "score": 0.3,
            "reason": "No contradiction analysis"
          },
          "traceability": {
            "score": 0.0,
            "reason": "0/0 claims have provenance"
          },
          "output_structure": {
            "score": 1.0,
            "reason": "Executive summary + confidence assessment"
          },
          "actionability": {
            "score": 1.0,
            "reason": "2 next steps, 3 data gaps identified"
          }
        },
        "weak_dimensions": [
          "evidence_support",
          "citation_validity",
          "mechanistic_specificity",
          "contradiction_handling",
          "traceability"
        ],
        "rerun_targets": [
          "LiteratureAgent",
          "MechanismAgent",
          "SynthesisCriticAgent"
        ]
      }
    },
    "8_risk_flags_limitations": {
      "risk_flags": [
        "Lack of direct evidence for Irinotecan in rectal signet ring cell adenocarcinoma."
      ],
      "limitations": [
        "The provided abstract is a case report focusing on metastases and diagnostic challenges, not treatment efficacy of specific drugs like Irinotecan."
      ],
      "missing_data": [
        "Information on Irinotecan's use in rectal signet ring cell adenocarcinoma.",
        "Details on the mechanism of action of Irinotecan in this specific cancer type.",
        "Clinical trial data or case studies involving Irinotecan for this indication."
      ]
    },
    "9_recommended_next_steps": {
      "clinical_next_steps": [
        "Search for studies investigating Irinotecan's efficacy in rectal signet ring cell adenocarcinoma.",
        "Investigate the known mechanisms of Irinotecan and its potential targets relevant to signet ring cell carcinoma."
      ]
    },
    "10_claim_evidence_table": {
      "total_claims": 0,
      "claims": []
    },
    "11_provenance_appendix": {
      "total_entries": 0,
      "entries": []
    }
  },
  "metadata": {
    "run_id": "84a17784e992",
    "created_at": "2026-06-03T11:49:46.822622+00:00",
    "drug": "IRINOTECAN",
    "disease": "rectal signet ring cell adenocarcinoma",
    "total_claims": 0,
    "quality_score": 0.3875,
    "reruns": 2
  }
}
```
